Seunghyeop Baek1, Sohyun Ahn2, Eunbin Ju3,4, Nuri Hyun Jung3. 1. Department of Radiological Science, Yonsei University, Wonju, Republic of Korea. 2. Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea; mpsohyun@gmail.com. 3. Department of Radiation Oncology, Kangwon National University Hospital, Kangwon, Republic of Korea. 4. Department of Bio-medical Science, Graduate School of Korea University, Sejong, Republic of Korea.
Abstract
BACKGROUND/AIM: In this study, a new method to create a customized three-dimensional (3D) bolus by accurately considering the anatomy of an individual patient is demonstrated. PATIENTS AND METHODS: A 3D bolus structure was created from an extended planning target volume (PTV) to reduce an inevitable skin reaction. In addition, during computed tomography simulation in patients with oral cavity cancers, a balloon was inserted into the mouth of a patient to secure space, and then the area surrounding the balloon was designed into a 3D bolus structure. RESULTS: For patients with head and neck cancers, a customized 3D bolus can reduce the unnecessary skin dose by 14.4% compared to a commercial bolus. For patients with oral cavity cancer, the PTV and tongue doses were 93.8% and 8% of the prescribed dose, respectively. CONCLUSION: The customized 3D bolus enables effective skin sparing and full coverage of the target area. Copyright
BACKGROUND/AIM: In this study, a new method to create a customized three-dimensional (3D) bolus by accurately considering the anatomy of an individual patient is demonstrated. PATIENTS AND METHODS: A 3D bolus structure was created from an extended planning target volume (PTV) to reduce an inevitable skin reaction. In addition, during computed tomography simulation in patients with oral cavity cancers, a balloon was inserted into the mouth of a patient to secure space, and then the area surrounding the balloon was designed into a 3D bolus structure. RESULTS: For patients with head and neck cancers, a customized 3D bolus can reduce the unnecessary skin dose by 14.4% compared to a commercial bolus. For patients with oral cavity cancer, the PTV and tongue doses were 93.8% and 8% of the prescribed dose, respectively. CONCLUSION: The customized 3D bolus enables effective skin sparing and full coverage of the target area. Copyright
Authors: Alison M Rose-Ped; Lisa A Bellm; Joel B Epstein; Andy Trotti; Clement Gwede; Henry J Fuchs Journal: Cancer Nurs Date: 2002-12 Impact factor: 2.592
Authors: Vladimir V Popov; Gary Muller-Kamskii; Aleksey Kovalevsky; Georgy Dzhenzhera; Evgeny Strokin; Anastasia Kolomiets; Jean Ramon Journal: Biomed Eng Lett Date: 2018-07-12
Authors: Richard A Canters; Irene M Lips; Markus Wendling; Martijn Kusters; Marianne van Zeeland; Rianne M Gerritsen; Philip Poortmans; Cornelia G Verhoef Journal: Radiother Oncol Date: 2016-07-27 Impact factor: 6.280
Authors: K K Fu; T F Pajak; A Trotti; C U Jones; S A Spencer; T L Phillips; A S Garden; J A Ridge; J S Cooper; K K Ang Journal: Int J Radiat Oncol Biol Phys Date: 2000-08-01 Impact factor: 7.038